Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis

被引:36
|
作者
Kaunisto, Jaana [1 ,2 ]
Kelloniemi, K. [3 ,4 ]
Sutinen, E. [5 ,6 ]
Hodgson, U. [5 ,6 ]
Piilonen, A. [3 ,4 ]
Kaarteenaho, R. [7 ,8 ,9 ,10 ]
Makitaro, R. [8 ,11 ]
Purokivi, M. [10 ]
Lappi-Blanco, E. [12 ,13 ,14 ]
Saarelainen, S. [15 ]
Kankaanranta, H. [16 ,17 ]
Mursu, A. [18 ,19 ]
Kanervisto, M. [20 ]
Salomaa, E-R. [21 ]
Myllaerniemi, M. [22 ,23 ,24 ]
机构
[1] Univ Turku, Turku Univ Hosp, Div Med, Pulm Dis, Turku, Finland
[2] Univ Turku, Dept Pulm Dis & Clin Allergol, Turku, Finland
[3] Univ Helsinki, HUS Med Imaging Ctr, Radiol, Helsinki, Finland
[4] Helsinki Univ Hosp, Helsinki, Finland
[5] Univ Helsinki, Helsinki, Finland
[6] Helsinki Univ Cent Hosp, Heart & Lung Ctr, Helsinki, Finland
[7] Univ Oulu, Dept Internal Med, Resp Dis, Oulu, Finland
[8] Oulu Univ Hosp, Med Res Ctr, Resp Res Unit, Oulu, Finland
[9] Univ Eastern Finland, Unit Med & Clin Res, Div Pulm, Kuopio, Finland
[10] Kuopio Univ Hosp, Div Resp Med, Ctr Med & Clin Res, SF-70210 Kuopio, Finland
[11] Univ Oulu, Dept Internal Med, Resp Dis, Inst Clin Med, SF-90220 Oulu, Finland
[12] Oulu Univ Hosp, Dept Pathol, Oulu, Finland
[13] Oulu Univ, Oulu, Finland
[14] Med Res Ctr Oulu, Oulu, Finland
[15] Tampere Univ Hosp, Dept Resp Med, Tampere, Finland
[16] Seinajoki Cent Hosp, Dept Resp Med, Seinajoki, Finland
[17] Univ Tampere, Dept Resp Med, FIN-33101 Tampere, Finland
[18] City Hosp Oulu, Oulu, Finland
[19] Hoitoketju Coronaria Oy, Oulu, Finland
[20] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland
[21] Univ Turku, Turku, Finland
[22] Univ Helsinki, Helsinki, Finland
[23] Helsinki Univ Hosp, Heart & Lung Ctr, Helsinki, Finland
[24] Helsinki Univ Hosp, Transplantat Lab, Helsinki, Finland
来源
BMC PULMONARY MEDICINE | 2015年 / 15卷
基金
芬兰科学院;
关键词
Idiopathic pulmonary fibrosis; Register; Epidemiology; SURVIVAL; PREVALENCE; REGISTRY; TRIALS; SYSTEM;
D O I
10.1186/s12890-015-0074-3
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The FinnishIPF registry is a prospective, longitudinal national registry study on the epidemiology of idiopathic pulmonary fibrosis (IPF). It was designed to describe the characteristics, management and prognosis of prevalent and incident IPF patients. The study was initiated in 2012. Methods: We present here results limited to five university hospitals. Patients with IPF were screened from hospital registries using ICD-10 diagnosis codes J84.1 and J84.9. All patients who gave informed consent were included and evaluated using novel diagnostic criteria. Point prevalence on the 31st of December in 2012 was calculated using the reported population in each university hospital city as the denominator. Results: Patients with ICD-10 codes J84.1 and J84.9 yielded a heterogeneous group - on the basis of patient records assessed by pulmonologists only 20-30 % of the cases were IPF. After clinical, radiological and histological re-evaluation 111 of 123 (90 %) of patients fulfilled the clinical criteria of IPF. The estimated prevalence of IPF was 8.6 cases/100 000. 60.4 % were men. Forty four percent of the patients were never-smokers. At diagnosis, the patients' mean age was 73.5 years and mean FVC was 80.4 % and DLCO 57.3 % of predicted. Conclusions: Our results suggest that hospital registries are inaccurate for epidemiological studies unless patients are carefully re-evaluated. IPF is diagnosed in Finland at a stage when lung function is still quite well preserved. Smoking in patients with IPF was less common than in previous reports.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis
    Jaana Kaunisto
    K. Kelloniemi
    E. Sutinen
    U. Hodgson
    A. Piilonen
    R. Kaarteenaho
    R. Mäkitaro
    M. Purokivi
    E. Lappi-Blanco
    S. Saarelainen
    H. Kankaanranta
    A. Mursu
    M. Kanervisto
    E-R. Salomaa
    M. Myllärniemi
    BMC Pulmonary Medicine, 15
  • [2] Evaluation of clinical diagnostic guidelines for idiopathic pulmonary fibrosis
    Bodineau, JLLC
    Izquierdo, LG
    Becerra, ER
    Juan, JM
    Cascos, MF
    Naranjo, FB
    Gómez, JC
    ARCHIVOS DE BRONCONEUMOLOGIA, 2003, 39 (01): : 23 - 28
  • [3] Diagnostic Approaches for Idiopathic Pulmonary Fibrosis
    Lee, Jae Ha
    Song, Jin Woo
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2024, 87 (01) : 40 - 51
  • [4] Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
    Jo, Helen E.
    Glaspole, Ian
    Goh, Nicole
    Hopkins, Peter M. A.
    Moodley, Yuben
    Reynolds, Paul N.
    Chapman, Sally
    Walters, Eugene Haydn
    Zappala, Christopher
    Allan, Heather
    Macansh, Sacha
    Grainge, Christopher
    Keir, Gregory J.
    Hayen, Andrew
    Henderson, Douglas
    Klebe, Sonja
    Heinze, Stefan B.
    Miller, Anne
    Rouse, Hannah C.
    Duhig, Edwina
    Cooper, Wendy A.
    Mahar, Annabelle M.
    Ellis, Samantha
    McCormack, Samuel R.
    Ng, Bernard
    Godbolt, David B.
    Corte, Tamera J.
    RESPIROLOGY, 2019, 24 (04) : 361 - 368
  • [5] Idiopathic Pulmonary Fibrosis: Diagnosis and Prognostic Evaluation
    Poletti, Venerino
    Ravaglia, Claudia
    Buccioli, Matteo
    Tantalocco, Paola
    Piciucchi, Sara
    Dubini, Alessandra
    Carloni, Angelo
    Chilosi, Marco
    Tomassetti, Sara
    RESPIRATION, 2013, 86 (01) : 5 - 12
  • [6] Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis
    Enomoto, Noriyuki
    Oyama, Yoshiyuki
    Enomoto, Yasunori
    Mikamo, Masashi
    Karayama, Masato
    Hozumi, Hironao
    Suzuki, Yuzo
    Kono, Masato
    Furuhashi, Kazuki
    Fujisawa, Tomoyuki
    Inui, Naoki
    Nakamura, Yutaro
    Suda, Takafumi
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (08) : 2378 - 2389
  • [7] Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data
    Kaunisto, Jaana
    Salomaa, Eija-Riitta
    Hodgson, Ulla
    Kaarteenaho, Riitta
    Myllarniemi, Marjukka
    BMC PULMONARY MEDICINE, 2013, 13
  • [8] Managing diagnostic procedures in idiopathic pulmonary fibrosis
    Wells, Athol U.
    EUROPEAN RESPIRATORY REVIEW, 2013, 22 (128) : 158 - 162
  • [9] A safety evaluation of pirfenidone for the treatment of idiopathic pulmonary fibrosis
    Anderson, Adam
    Shifren, Adrian
    Nathan, Steven D.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (07) : 975 - 982
  • [10] Prevalence of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis: Correlation with Physiological Parameters
    Papakosta, D.
    Pitsiou, G.
    Daniil, Z.
    Dimadi, M.
    Stagaki, E.
    Rapti, A.
    Antoniou, K.
    Tzouvelekis, A.
    Kontakiotis, T.
    Tryfon, S.
    Polychronopoulos, V.
    Bouros, D.
    LUNG, 2011, 189 (05) : 391 - 399